N-Nitrosodiethylamine-Induced Pig Liver Hepatocellular Carcinoma Model: Radiological and Histopathological Studies

被引:0
作者
Xiao Li
Xiangping Zhou
Yongsong Guan
Yi-Xiang J. Wang
Diane Scutt
Qi-Yong Gong
机构
[1] West China Hospital,Department of Radiology
[2] Sichuan University,Department of Radiology
[3] Rui Jin Hospital,Department of Medical Imaging
[4] Shanghai Second Medical University,undefined
[5] University of Liverpool,undefined
[6] AstraZeneca R&D Alderley,undefined
来源
CardioVascular and Interventional Radiology | 2006年 / 29卷
关键词
Hepatocellular carcinoma; -Nitrosodiethylamine; Animal model; Pig;
D O I
暂无
中图分类号
学科分类号
摘要
Experimental research involving animal models plays a critical role in the development and improvement of minimally invasive therapies for hepatocellular carcinoma (HCC). As a large animal, the pig is commonly used for surgery and interventional radiology research. In this study, liver multicentric HCC with cirrhosis was induced in six China Taihu pigs by intraperitoneal injection of 10 mg/kg of N-nitrosodiethylamine once a week for 3 months, followed by a period of 10–12 months without N-nitrosodiethylamine treatment. All pigs were in generally good health until the end of the study. The tumor nodules appeared hyperattenuating in the arterial phase of a dynamic computed tomography (CT) scan. Digital subtraction angiography (DSA) and CT angiography demonstrated that the tumors derived their blood supply mainly from the hepatic artery system. Lipiodol-CT showed Lipiodol retention in tumor areas. The histology and electron microscopic ultrastructure of the chemically induced liver HCC in this study resembled human HCC with a cirrhosis background. An immunohistochemistry study confirmed that the tumors were of hepatocyte origin. All highly, moderately, and poorly differentiated HCC tumors were identified in this study. Cholangiocarcinoma was not seen in any of the animals. Due to its comparable size to human anatomy, the pig liver HCC model would give a better scope for interventional and surgical manipulations than small animal models.
引用
收藏
页码:420 / 428
页数:8
相关论文
共 77 条
  • [1] Parkin DM(2001)Estimating the world cancer burden: Globocan 2000 J Cancer 94 153-156
  • [2] Bray F(1999)Epidemiology of primary liver cancer Semin Liver Dis 19 271-285
  • [3] Ferlay J(1998)Surgical treatment of hepatocellular carcinoma on cirrhosis: A Western experience Hepatogastroenterology 45 1281-1287
  • [4] Bosch FX(1998)Transcatheter arterial chemoembolization of hepatocellular carcinoma Hepatogastroenterology 45 1236-1241
  • [5] Ribes J(2004)Hepatic arterial Liver Transplant 10 S107-S110
  • [6] Borras J(2004)yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients Psychooncology 13 73-79
  • [7] Mazziotti A(1998)Quality of life in patients diagnosed with primary hepatocellular carcinoma: Hepatic arterial infusion of Cisplatin versus 90-yttrium microspheres (Therasphere) Hepatology 27 67-72
  • [8] Grazi GL(1999)Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma Cancer 85 1694-1702
  • [9] Cavallari A(2002)Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma: Comparison with percutaneous ethanol injection therapy Radiology 223 331-337
  • [10] Chung JW(2002)Small hepatocellular carcinoma: Comparison of radio-frequency ablation and percutaneous microwave coagulation therapy Arch Surg 137 1332-1339